1 / 7

Outpatient Oncology Infusion Market

Outpatient Oncology Infusion Market

IRFAN13
Download Presentation

Outpatient Oncology Infusion Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Outpatient Oncology Infusion Market, Share, Growth, Trends and Forecast to 2030: Global Market Insights © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  2. Global Outpatient Oncology Infusion Market • The global outpatient oncology infusion market is expected to register commendable growth by 2030, due in part to the rising prevalence of cancer cases and growing investment interest towards R&D for cancer treatment worldwide. • Outpatient oncology infusion therapy is rapidly emerging as a major component of modern cancer treatment protocols. Infusion therapy refers to procedures where medicine is administered directly into the bloodstream of the patient to shrink or curb the growth of cancer cells. • Outpatient infusion therapies for cancer treatment encompass various services, including hormone therapy, immunotherapy, chemotherapy, and blood transfusions, as well as other infusion treatments the patient may require, like antibiotics, pain medication, and hydration fluids. • The global outpatient oncology infusion market is bifurcated in terms of product, application, therapy, mode, and region. • To access a sample copy or view the market report in detail along with the table of • contents, please click the link below:https://www.gminsights.com/request-sample/detail/5268 © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  3. Continue:- • With respect to product, the outpatient oncology infusion industry is further classified into intravenous sets, infusion pumps, needleless connectors, and IV cannulas. • Of these, the IV cannulas segment registered revenues worth nearly $4 billion in 2021. This was credited largely to a rising adoption of IV cannulas for the infusion of medication or collection of blood samples in investigational medical processes. • Based on application, the outpatient oncology infusion market is segregated into liver cancer, lung cancer, prostate cancer, breast cancer, and others. • The liver cancer segment held a 3.9% share of the overall market in 2021, given the rapid rise in the prevalence of liver cancer, as well as the escalating demand for infusion therapies like targeted therapy or immunotherapy. • In February 2022, for instance, oncologists and surgeons at Penn Medicine's Department of Surgery used adjuvant hepatic artery infusion chemotherapy along with systemic chemotherapy, in order to treat unresectable CLMs (colorectal liver metastases) or mitigate the risk of recurrence among individuals with resected CLMs. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  4. 360° Industry Analysis • Browse key industry insights spread across 140 pages with 115 market data tables & 14 figures & charts from the report, “Outpatient Oncology Infusion Market Size By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy), By Mode (Intramuscular (IM), Intravenous (IV), Subcutaneous), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:https://www.gminsights.com/industry-analysis/outpatient-oncology-infusion-market • From a therapy perspective, the outpatient oncology infusion industry is categorized into targeted therapy, immunotherapy, chemotherapy, and hormonal therapy. The hormonal therapy segment recorded a remuneration of over $6 billion in 2021, driven by the growing prevalence of cancer across the globe. • Additionally, rising awareness among patients and physicians regarding the benefits of alternative cancer treatments like hormone therapy is a major driver propelling industry growth. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  5. Partial Table of Contents (ToC) of the report: • Chapter 1   Methodology • 1.1    Methodology • 1.2    Market definitions • 1.3    Forecast parameters • 1.4    Data sources • 1.4.1    Secondary • 1.4.1.1   Paid sources • 1.4.1.2   Unpaid sources • 1.4.2    Primary • Chapter 2   Executive Summary • 2.1    Outpatient oncology infusion industry 360° synopsis, 2017 - 2030 • 2.1.1    Business trends • 2.1.2    Product trends • 2.1.3    Application trends • 2.1.4    Therapy trends • 2.1.5    Mode trends • 2.1.6    Regional trends © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  6. Key player : • B. Braun Melsungen AG, • Baxter,  • Becton, • Dickinson, and Company, • Fresenius Kabi,  • ICU Medical, Inc., • IRadimed Corporation, • Nipro Corporation,  • Terumo Corporation,  • Smiths Medical,  • Medtronic PLC, • Roche Diagnostics,  • Teleflex, Inc.,  • Browse complete table of content of this report@https://www.gminsights.com/industry-analysis/outpatient-oncology-infusion-market

  7. Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

More Related